|
(+)-Aeroplysinin-1 |
|
|
ALX-350-256-M001 |
|
1 mg |
70.00 USD |
|
 |
|
|
ALK5 Inhibitor I |
|
|
ALX-270-448-M001 |
|
1 mg |
30.00 USD |
|
|
|
ALX-270-448-M005 |
|
5 mg |
90.00 USD |
|
|
|
|
ALK5 Inhibitor II |
|
|
ALX-270-445-M001 |
|
1 mg |
60.00 USD |
|
|
|
ALX-270-445-M005 |
|
5 mg |
240.00 USD |
|
|
|
|
Asterric acid |
|
|
ALX-380-208-M001 |
|
1 mg |
220.00 USD |
|
|
|
|
BAY 43-9006 |
|
|
ALX-270-469-M001 |
|
1 mg |
80.00 USD |
|
|
|
ALX-270-469-M005 |
|
5 mg |
320.00 USD |
|
|
|
|
pro-Bone Morphogenetic Protein 2 (human) (recombinant) |
|
|
ALX-201-204/1-C010 |
|
10 µg |
380.00 USD |
|
|
|
|
Bone Morphogenetic Protein 2 (human) (recombinant) |
|
|
ALX-201-205/1-C010 |
|
10 µg |
280.00 USD |
|
|
|
|
BPIQ-I |
|
|
ALX-270-313-M001 |
|
1 mg |
140.00 USD |
|
|
|
|
BPIQ-II |
|
|
ALX-270-338-M001 |
|
1 mg |
140.00 USD |
|
|
|
|
Butein |
|
|
ALX-350-246-M010 |
|
10 mg |
190.00 USD |
|
|
|
|
CDK1/2 Inhibitor III |
|
|
ALX-270-442-M001 |
|
1 mg |
118.00 USD |
|
|
|
|
CL-387,785 |
|
|
ALX-270-314-M001 |
|
1 mg |
130.00 USD |
|
|
|
|
Compound 56 |
|
|
ALX-270-316-C500 |
|
500 µg |
135.00 USD |
|
|
|
|
Curcumin (high purity) |
|
|
ALX-350-028-M010 |
|
10 mg |
15.00 USD |
|
|
|
ALX-350-028-M050 |
|
50 mg |
60.00 USD |
|
|
|
ALX-350-028-M250 |
|
250 mg |
240.00 USD |
|
|
|
|
Daphnetin |
|
|
ALX-270-281-M005 |
|
5 mg |
25.00 USD |
|
|
|
ALX-270-281-M025 |
|
25 mg |
95.00 USD |
|
|
|
|
EGF Receptor (human) (651-658) |
|
|
ALX-155-021-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-155-021-M005 |
|
5 mg |
200.00 USD |
|
|
|
|
EGF Receptor (human) (651-658) (N-Myristoylated) |
|
|
ALX-155-022-M001 |
|
1 mg |
60.00 USD |
|
|
|
ALX-155-022-M005 |
|
5 mg |
240.00 USD |
|
|
|
|
EGF Receptor (human) (652-657) |
|
|
ALX-155-023-M001 |
|
1 mg |
45.00 USD |
|
|
|
ALX-155-023-M005 |
|
5 mg |
180.00 USD |
|
|
|
|
EGF Receptor, Soluble (active) (human) ELISA Kit |
|
|
ALX-850-266-KI01 |
|
1 Kit |
664.00 USD |
|
|
|
|
(-)-Epigallocatechin gallate |
|
|
ALX-270-263-M010 |
|
10 mg |
20.00 USD |
|
|
|
ALX-270-263-M050 |
|
50 mg |
60.00 USD |
|
|
|
